找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Continuous Dopaminergic Stimulation in Parkinson’s Disease; Proceedings of the W J. A. Obeso,R. Horowski,C. D. Marsden Conference proceedin

[复制链接]
楼主: VER
发表于 2025-3-26 22:38:38 | 显示全部楼层
https://doi.org/10.1007/978-3-322-80731-1infusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
发表于 2025-3-27 03:04:14 | 显示全部楼层
发表于 2025-3-27 07:14:10 | 显示全部楼层
发表于 2025-3-27 11:00:59 | 显示全部楼层
Continuous subcutaneous lisuride infusions in Parkinson’s diseaseinfusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
发表于 2025-3-27 14:18:46 | 显示全部楼层
Pharmacokinetics of lisuride after subcutaneous infusiontion of the infusion, concentrations declined with a half-life of 1.4 ± 0.4 hour. The total clearance of lisuride was 20 ± 6 ml/min/kg. Due to the low interpatient variability of plasma levels, a good control of clinical effects is to be expected.
发表于 2025-3-27 18:32:34 | 显示全部楼层
Lisuride infusion pump in Parkinson’s disease. A report of two casesough a net increase in the number of hours spent “on”. Dyskinesias remained unmodified. Limiting psychiatric side effects were observed in one of the patients..Practical and technical aspects of the management of this therapeutic method are discussed.
发表于 2025-3-28 00:15:38 | 显示全部楼层
Pathogenetic studies of motor fluctuations in Parkinson’s diseasete advanced Parkinson’s disease. Since levodopa clearance from the general circulation was found to be similar in patients with wearing-off or on-off phenomena and those with a stable response to levodopa, peripheral pharmacokinetic factors are unlikely to be involved. Efficacy half-time for levodop
发表于 2025-3-28 05:37:09 | 显示全部楼层
The case for and concerns about continuous dopamine stimulation in Parkinson’s diseaseluctations in response (“on-off”). This should be manageable with innovative delivery systems for the drugs. However further studies are required to determine if continuous dopaminergic stimulation will be complicated by increased levels of drug metabolites or down regulation of dopaminergic neurotr
发表于 2025-3-28 07:24:51 | 显示全部楼层
发表于 2025-3-28 12:56:34 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-6 00:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表